寻找可能避免止血的新抗血栓形成机制和疗法。
The search for new antithrombotic mechanisms and therapies that may spare hemostasis.
机构信息
Cleveland Clinic Foundation; and.
Harrington Heart & Vascular Institute, University Hospitals Cleveland Medical Center, Case Cardiovascular Research Institute, Case Western Reserve University School of Medicine, Cleveland, OH.
出版信息
Blood. 2018 Apr 26;131(17):1899-1902. doi: 10.1182/blood-2017-10-784074. Epub 2018 Feb 21.
Abstract
Current antithrombotic drugs, including widely used antiplatelet agents and anticoagulants, are associated with significant bleeding risk. Emerging experimental evidence suggests that the molecular and cellular mechanisms of hemostasis and thrombosis can be separated, thereby increasing the possibility of new antithrombotic therapeutic targets with reduced bleeding risk. We review new coagulation and platelet targets and highlight the interaction between integrin αβ (Mac-1, CD11b/CD18) on leukocytes and GPIbα on platelets that seems to distinguish thrombosis from hemostasis.
摘要
目前的抗血栓药物，包括广泛使用的抗血小板药物和抗凝剂，都与显著的出血风险相关。新兴的实验证据表明，止血和血栓形成的分子和细胞机制可以分离，从而增加了具有降低出血风险的新型抗血栓治疗靶点的可能性。我们回顾了新的凝血和血小板靶点，并强调了白细胞上的整合素 αβ（Mac-1、CD11b/CD18）与血小板上的 GPIbα 之间的相互作用，这种相互作用似乎可以区分血栓形成和止血。
相似文献
1
The search for new antithrombotic mechanisms and therapies that may spare hemostasis.寻找可能避免止血的新抗血栓形成机制和疗法。
Blood. 2018 Apr 26;131(17):1899-1902. doi: 10.1182/blood-2017-10-784074. Epub 2018 Feb 21.
2
Leukocyte integrin Mac-1 regulates thrombosis via interaction with platelet GPIbα.白细胞整合素 Mac-1 通过与血小板 GPIbα 相互作用调节血栓形成。
Nat Commun. 2017 May 30;8:15559. doi: 10.1038/ncomms15559.
3
LIM kinase-1 selectively promotes glycoprotein Ib-IX-mediated TXA2 synthesis, platelet activation, and thrombosis.LIM 激酶-1 选择性促进糖蛋白 Ib-IX 介导的 TXA2 合成、血小板活化和血栓形成。
Blood. 2013 May 30;121(22):4586-94. doi: 10.1182/blood-2012-12-470765. Epub 2013 Apr 25.
4
Inhibition of platelet glycoprotein Ib and its antithrombotic potential.血小板糖蛋白Ib的抑制作用及其抗血栓形成潜力。
Curr Pharm Des. 2007;13(26):2684-97. doi: 10.2174/138161207781662867.
5
WY-14643, a novel antiplatelet and antithrombotic agent targeting the GPIbα receptor.WY-14643，一种新型抗血小板和抗血栓药物，靶向 GPIbα 受体。
Thromb Res. 2024 Jun;238:41-51. doi: 10.1016/j.thromres.2024.04.011. Epub 2024 Apr 16.
6
Platelet GPIb complex as a target for anti-thrombotic drug development.血小板糖蛋白Ib复合物作为抗血栓药物研发的靶点。
Thromb Haemost. 2008 Mar;99(3):473-9. doi: 10.1160/TH07-12-0718.
7
Dual roles of fucoidan-GPIbα interaction in thrombosis and hemostasis: implications for drug development targeting GPIbα.岩藻聚糖硫酸酯-GPIbα 相互作用在血栓形成和止血中的双重作用：对靶向 GPIbα 的药物开发的意义。
J Thromb Haemost. 2023 May;21(5):1274-1288. doi: 10.1016/j.jtha.2022.12.030. Epub 2023 Jan 9.
8
Novel Antithrombotic Drugs on the Horizon: The Ultimate Promise to Prevent Clotting While Avoiding Bleeding.新型抗血栓药物即将问世：预防凝血同时避免出血的终极承诺。
Circ Res. 2017 Oct 27;121(10):1133-1135. doi: 10.1161/CIRCRESAHA.117.312012.
9
Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis. Amphibatide，一种新型的 GPIb 复合物拮抗剂，能够抑制体外和体内血栓形成的小鼠模型中的血小板黏附和血栓形成。
Thromb Haemost. 2014 Feb;111(2):279-89. doi: 10.1160/TH13-06-0490. Epub 2013 Oct 31.
10
Lentiviral gene rescue of a Bernard-Soulier mouse model to study platelet glycoprotein Ibβ function.慢病毒基因拯救 Bernard-Soulier 小鼠模型，用于研究血小板糖蛋白 Ibβ 功能。
J Thromb Haemost. 2016 Jul;14(7):1470-9. doi: 10.1111/jth.13355. Epub 2016 Jul 14.
引用本文的文献
1
Prehospital tranexamic acid decreases early mortality in trauma patients: a systematic review and meta-analysis.院前应用氨甲环酸可降低创伤患者的早期死亡率：一项系统评价和荟萃分析。
Front Med (Lausanne). 2025 Mar 14;12:1552271. doi: 10.3389/fmed.2025.1552271. eCollection 2025.
2
Platelet Proteomics and Tissue Metabolomics Investigation for the Mechanism of Aspirin Eugenol Ester on Preventive Thrombosis Mechanism in a Rat Thrombosis Model.血小板蛋白质组学和组织代谢组学研究阿司匹林丁香酚酯在大鼠血栓模型中预防血栓形成机制的作用。
Int J Mol Sci. 2024 Oct 6;25(19):10747. doi: 10.3390/ijms251910747.
3
Factor XIa inhibition as a therapeutic strategy for atherothrombosis.抑制因子XIa作为动脉粥样硬化血栓形成的一种治疗策略。
J Thromb Thrombolysis. 2024 Dec;57(8):1297-1307. doi: 10.1007/s11239-024-03023-9. Epub 2024 Jul 29.
4
CD11b maintains West Nile virus replication through modulation of immune response in human neuroblastoma cells.CD11b 通过调节人神经母细胞瘤细胞的免疫反应来维持西尼罗河病毒的复制。
Virol J. 2024 Jul 14;21(1):158. doi: 10.1186/s12985-024-02427-6.
5
Protein disulfide isomerase cleaves allosteric disulfides in histidine-rich glycoprotein to regulate thrombosis.蛋白质二硫键异构酶切割组氨酸丰富糖蛋白中的变构二硫键以调节血栓形成。
Nat Commun. 2024 Apr 11;15(1):3129. doi: 10.1038/s41467-024-47493-0.
6
Platelet-Mimicking Nanosponges for Functional Reversal of Antiplatelet Agents.血小板模拟纳米海绵用于抗血小板药物功能逆转。
Circ Res. 2023 Feb 3;132(3):339-354. doi: 10.1161/CIRCRESAHA.122.321034. Epub 2023 Jan 10.
7
Specific signature biomarkers highlight the potential mechanisms of circulating neutrophils in aneurysmal subarachnoid hemorrhage.特定的标志性生物标志物揭示了循环中性粒细胞在动脉瘤性蛛网膜下腔出血中的潜在机制。
Front Pharmacol. 2022 Nov 10;13:1022564. doi: 10.3389/fphar.2022.1022564. eCollection 2022.
8
A Novel Marine Pyran-Isoindolone Compound Enhances Fibrin Lysis Mediated by Single-Chain Urokinase-Type Plasminogen Activator.一种新型海洋吡喃异吲哚啉化合物增强单链尿激酶型纤溶酶原激活剂介导的纤维蛋白溶解。
Mar Drugs. 2022 Jul 30;20(8):495. doi: 10.3390/md20080495.
9
Antithrombotic Therapy Improves ICU Mortality of Septic Patients with Peripheral Vascular Disease.抗血栓治疗改善外周血管疾病合并脓毒症患者 ICU 死亡率。
Int J Clin Pract. 2022 Mar 16;2022:1288535. doi: 10.1155/2022/1288535. eCollection 2022.
10
Factor XI Inhibitors for Prevention and Treatment of Venous Thromboembolism: A Review on the Rationale and Update on Current Evidence.用于预防和治疗静脉血栓栓塞的凝血因子XI抑制剂：理论依据综述及当前证据更新
Front Cardiovasc Med. 2022 May 12;9:903029. doi: 10.3389/fcvm.2022.903029. eCollection 2022.
本文引用的文献
1
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease.卡那奴单抗治疗动脉粥样硬化疾病的抗炎疗法。
N Engl J Med. 2017 Sep 21;377(12):1119-1131. doi: 10.1056/NEJMoa1707914. Epub 2017 Aug 27.
2
Corrigendum: Leukocyte integrin Mac-1 regulates thrombosis via interaction with platelet GPIbα.勘误：白细胞整合素Mac-1通过与血小板糖蛋白Ibα相互作用调节血栓形成。
Nat Commun. 2017 Jul 4;8:16124. doi: 10.1038/ncomms16124.
3
Factors XI and XII as Targets for New Anticoagulants.作为新型抗凝剂靶点的因子XI和因子XII。
Front Med (Lausanne). 2017 Feb 24;4:19. doi: 10.3389/fmed.2017.00019. eCollection 2017.
4
Neutrophil Counts and Initial Presentation of 12 Cardiovascular Diseases: A CALIBER Cohort Study.中性粒细胞计数与12种心血管疾病的初始表现：一项CALIBER队列研究
J Am Coll Cardiol. 2017 Mar 7;69(9):1160-1169. doi: 10.1016/j.jacc.2016.12.022.
5
Gα13 Switch Region 2 Relieves Talin Autoinhibition to Activate αIIbβ3 Integrin.Gα13开关区域2解除踝蛋白自身抑制以激活αIIbβ3整合素。
J Biol Chem. 2016 Dec 23;291(52):26598-26612. doi: 10.1074/jbc.M116.747279. Epub 2016 Nov 1.
6
Factor XI and factor XII as targets for new anticoagulants.作为新型抗凝剂靶点的凝血因子XI和凝血因子XII。
Thromb Res. 2016 May;141 Suppl 2:S40-5. doi: 10.1016/S0049-3848(16)30363-2.
7
Factor XI antisense oligonucleotide for prevention of venous thrombosis.XI 因子反义寡核苷酸预防静脉血栓形成。
N Engl J Med. 2015 Jan 15;372(3):232-40. doi: 10.1056/NEJMoa1405760. Epub 2014 Dec 7.
8
Targeting integrin and integrin signaling in treating thrombosis.靶向整合素及整合素信号传导治疗血栓形成
Arterioscler Thromb Vasc Biol. 2015 Jan;35(1):24-9. doi: 10.1161/ATVBAHA.114.303411. Epub 2014 Sep 25.
9
Shaping the platelet response to vascular injury.塑造血小板对血管损伤的反应。
Curr Opin Hematol. 2014 Sep;21(5):410-7. doi: 10.1097/MOH.0000000000000070.
10
Platelet-derived S100 family member myeloid-related protein-14 regulates thrombosis.血小板衍生 S100 家族成员髓系相关蛋白-14 调节血栓形成。
J Clin Invest. 2014 May;124(5):2160-71. doi: 10.1172/JCI70966. Epub 2014 Apr 1.
Zotero 插件